tradingkey.logo

Becton Dickinson and Co

BDX
187.630USD
+5.990+3.30%
Horário de mercado ETCotações atrasadas em 15 min
53.78BValor de mercado
32.05P/L TTM

Becton Dickinson and Co

187.630
+5.990+3.30%

Mais detalhes de Becton Dickinson and Co Empresa

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Informações de Becton Dickinson and Co

Código da empresaBDX
Nome da EmpresaBecton Dickinson and Co
Data de listagemSep 25, 1963
CEOMr. Thomas E. Polen
Número de funcionários74000
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 25
EndereçoOne Becton Drive
CidadeFRANKLIN LAKES
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal07417-1880
Telefone12018476800
Sitehttps://www.bd.com/
Código da empresaBDX
Data de listagemSep 25, 1963
CEOMr. Thomas E. Polen

Executivos da empresa Becton Dickinson and Co

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
754.43K
-0.03%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
47.02K
-3.86%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.21K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Director
Independent Director
9.14K
+11.33%
Mr. Michael Feld
Mr. Michael Feld
Executive Vice President, President - Life Sciences
Executive Vice President, President - Life Sciences
8.25K
-0.69%
Ms. Michelle Quinn
Ms. Michelle Quinn
Executive Vice President, General Counsel
Executive Vice President, General Counsel
6.93K
+39.80%
Mr. Gregory J. Hayes
Mr. Gregory J. Hayes
Independent Director
Independent Director
6.05K
+659.55%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
754.43K
-0.03%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
47.02K
-3.86%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.21K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Medication Delivery Solutions
1.13B
20.55%
Medication Management Solutions
888.00M
16.12%
Pharmaceutical Systems
629.00M
11.42%
Peripheral Intervention
512.00M
9.29%
Specimen Management
470.00M
8.53%
Outro
1.88B
34.09%
Por RegiãoUSD
Nome
Receita
Proporção
United States
3.18B
57.72%
International
2.33B
42.26%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Medication Delivery Solutions
1.13B
20.55%
Medication Management Solutions
888.00M
16.12%
Pharmaceutical Systems
629.00M
11.42%
Peripheral Intervention
512.00M
9.29%
Specimen Management
470.00M
8.53%
Outro
1.88B
34.09%

Distribuição de ações

Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
11.27%
T. Rowe Price Investment Management, Inc.
5.64%
BlackRock Institutional Trust Company, N.A.
5.29%
State Street Investment Management (US)
4.68%
First Eagle Investment Management, L.L.C.
3.07%
Outro
70.05%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
11.27%
T. Rowe Price Investment Management, Inc.
5.64%
BlackRock Institutional Trust Company, N.A.
5.29%
State Street Investment Management (US)
4.68%
First Eagle Investment Management, L.L.C.
3.07%
Outro
70.05%
Tipos de investidores
Investidores
Proporção
Investment Advisor
49.37%
Investment Advisor/Hedge Fund
31.76%
Hedge Fund
3.60%
Research Firm
2.96%
Pension Fund
2.13%
Bank and Trust
1.65%
Sovereign Wealth Fund
1.38%
Individual Investor
0.57%
Insurance Company
0.32%
Outro
6.25%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
2848
265.27M
92.55%
-11.28M
2025Q2
2864
264.72M
92.36%
-14.86M
2025Q1
2897
269.10M
93.89%
-12.90M
2024Q4
2874
271.53M
94.56%
-4.62M
2024Q3
2787
266.29M
92.14%
-3.20M
2024Q2
2782
261.01M
90.31%
-2.68M
2024Q1
2797
255.99M
88.58%
-10.13M
2023Q4
2783
259.38M
89.78%
-7.79M
2023Q3
2768
264.64M
91.23%
-591.87K
2023Q2
2787
263.29M
90.78%
-570.64K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
32.17M
11.22%
+4.30M
+15.41%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
16.18M
5.64%
+3.60M
+28.65%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
15.15M
5.29%
+360.45K
+2.44%
Jun 30, 2025
State Street Investment Management (US)
13.41M
4.68%
-579.46K
-4.14%
Jun 30, 2025
First Eagle Investment Management, L.L.C.
8.79M
3.07%
+3.27M
+59.18%
Jun 30, 2025
T. Rowe Price Associates, Inc.
8.47M
2.95%
-2.43M
-22.27%
Jun 30, 2025
MFS Investment Management
7.69M
2.68%
+1.58M
+25.78%
Jun 30, 2025
Geode Capital Management, L.L.C.
6.72M
2.35%
+244.20K
+3.77%
Jun 30, 2025
ClearBridge Investments, LLC
3.80M
1.33%
+321.67K
+9.24%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
3.79M
1.32%
+551.15K
+17.00%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
iShares U.S. Medical Devices ETF
4.53%
American Century Focused Large Cap Value ETF
3.16%
Cullen Enhanced Equity Income ETF
3.07%
First Eagle Global Equity ETF
2.85%
iShares Large Cap Value Active ETF
2.73%
T Rowe Price Capital Appreciation Equity ETF
2.71%
Franklin ClearBridge Enhanced Income ETF
2.51%
Monarch Volume Factor Dividend Tree Index ETF
2.45%
Brandes US Value ETF
2.34%
Invesco Nasdaq Free Cash Flow Achievers ETF
1.89%
Ver Mais
iShares U.S. Medical Devices ETF
Proporção4.53%
American Century Focused Large Cap Value ETF
Proporção3.16%
Cullen Enhanced Equity Income ETF
Proporção3.07%
First Eagle Global Equity ETF
Proporção2.85%
iShares Large Cap Value Active ETF
Proporção2.73%
T Rowe Price Capital Appreciation Equity ETF
Proporção2.71%
Franklin ClearBridge Enhanced Income ETF
Proporção2.51%
Monarch Volume Factor Dividend Tree Index ETF
Proporção2.45%
Brandes US Value ETF
Proporção2.34%
Invesco Nasdaq Free Cash Flow Achievers ETF
Proporção1.89%

Dividendo

Um total de 5.54B USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jan 28, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Mar 31, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 31, 2025
Mar 10, 2025
Nov 07, 2024
BDX.NB Final Cash Dividend of gross USD 1.04 paid on Dec 31, 2024 going ex on Dec 09, 2024
Dec 09, 2024
Dec 31, 2024
Dec 09, 2024
Jul 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Sep 30, 2024 going ex on Sep 09, 2024
Sep 09, 2024
Sep 30, 2024
Sep 09, 2024
Apr 30, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Jun 28, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 28, 2024
Jun 10, 2024
Jan 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 29, 2024
Mar 07, 2024
Nov 09, 2023
BDX.NB Final Cash Dividend of gross USD 0.95 paid on Dec 29, 2023 going ex on Dec 07, 2023
Dec 08, 2023
Dec 29, 2023
Dec 07, 2023
Jul 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Sep 29, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 29, 2023
Sep 07, 2023
Apr 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Jun 30, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 30, 2023
Jun 08, 2023
Jan 24, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Mar 31, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 31, 2023
Mar 09, 2023
Nov 10, 2022
BDX.NB Final Cash Dividend of gross USD 0.91 paid on Dec 30, 2022 going ex on Dec 08, 2022
Dec 09, 2022
Dec 30, 2022
Dec 08, 2022
Ver Mais

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI